Cannabinoid-induced alterations in brain disposition of drugs of abuse

Biochemical Pharmacology

Volumn 61, Issue 11, 2001, Pages 1357-1367

  Reid, Michael J ^a   Bornheim, Lester M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cannabidiol; Drugs of abuse; Marijuana; Pharmacokinetics; Plasma protein binding; Tetrahydrocannabinol

Indexed keywords

AMPHETAMINE DERIVATIVE; CANNABIDIOL; CANNABINOID; CANNABIS; COCAINE; CYTOCHROME P450; METHADONE; METHYLENEDIOXYPHENYL METHAMPHETAMINE; MORPHINE SULFATE; NORCOCAINE; PHENCYCLIDINE; TETRAHYDROCANNABINOL; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ABUSE; DRUG BRAIN LEVEL; DRUG EFFECT; DRUG METABOLISM; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

ANESTHETICS, LOCAL; ANIMALS; BIOLOGICAL TRANSPORT; BRAIN; CANNABINOIDS; CANNABIS; COCAINE; DRUG INTERACTIONS; HALLUCINOGENS; MALE; MICE; PHENCYCLIDINE; PROTEIN BINDING; PSYCHOTROPIC DRUGS; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANCE-RELATED DISORDERS; TETRAHYDROCANNABINOL;

EID: 0035371589     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(01)00616-5     Document Type: Article

References (32)

1. Mechoulam R. Marijuana chemistry. Science. 168:1970;1159-1166.
2. Joy J.E., Watson S.J., Benson J. Marijuana and medicine assessing the science base . 1999;National Academy Press, Washington, DC.
3. Hollister L.E. Cannabidiol and cannabinol in man. Experientia. 29:1973;825-826.
4. Herkenham M., Lynn A.B, Little M.D., Johnson M.R., Melvin L.S., De Costa B.R., Rice K.C. Cannabinoid receptor localization in the brain. Proc Natl Acad Sci USA. 87:1990;1932-1936.
5. Bornheim L.M., Borys H.K., Karler R. Effect of cannabidiol on cytochrome P-450 and hexobarbital sleep time. Biochem Pharmacol. 30:1981;503-507.
6. Watanabe K., Hamajima K., Narimatsu S., Yamamoto I., Yoshimura H. Effects of two cannabinoids on hepatic microsomal cytochrome P-450. J Pharmacobio-dyn. 9:1986;39-45.
7. Bornheim L.M. Effect of cannabidiol on drug metabolism. Watson R.R. Biochemistry and physiology of substance abuse. vol. 1:1989;21-35 CRC Press, Boca Raton.
8. 9-tetrahydrocannabinol. Psychopharmacologia. 33:1973;53-70.
9. 9-tetrahydrocannabinol in man. Eur J Pharmacol. 28:1974;172-177.
10. Dalton W.S., Martz R., Lemberger L., Rodda B.E., Forney R.B. Influence of cannabidiol on delta-9-tetrahydrocannabinol effects. Clin Pharmacol Ther. 19:1976;300-309.
11. 9-THC in normal subjects. Psychopharmacology (Berl). 76:1982;245-250.
12. Bornheim L.M., Kim K.Y., Li J., Perotti B.Y.T., Benet L.Z. Effect of cannabidiol pretreatment on the kinetics of tetrahydrocannabinol metabolites in mouse brain. Drug Metab Dispos. 23:1995;825-831.
13. Rush C.R., Roll J.M., Higgins S.T. Controlled laboratory studies on the effects of cocaine in combination with other commonly abused drugs in humans. Higgins S.T., Katz J.L. Cocaine abuse behavior, pharmacology, and clinical applications . 1998;239-263 Academic Press, San Diego.
14. Smart R.G., Ogborne A.C., Newton-Taylor B. Drug abuse and alcohol problems among cocaine abusers in an assessment/referral service. Br J Addict. 85:1990;1595-1598.
15. Gorelick D.A., Wilkins J.N. Inpatient treatment of PCP abusers and users. Am J Drug Alcohol Abuse. 15:1989;1-12.
16. 1996 DAWN Annual Medical Examiner Data. In: DAWN Series D-4, DHHS Publication No. (SMA), 98-3228, p. 35. Rockville, MD: Public Health Service: Substance Abuse and Mental Health Services Administration, 1998.
17. Lukas S.E., Sholar M., Kouri E., Fukuzako H., Mendelson J.H. Marihuana smoking increases plasma cocaine levels and subjective reports of euphoria in male volunteers. Pharmacol Biochem Behav. 48:1994;715-721.
18. Bornheim L.M., Correia M.A. Purification and characterization of the major hepatic cannabinoid hydroxylase in the mouse a possible member of the cytochrome P-450IIC subfamily . Mol Pharmacol. 40:1991;228-234.
19. Bornheim L.M. Effect of cytochrome P450 inducers on cocaine-mediated hepatotoxicity. Toxicol Appl Pharmacol. 150:1998;158-165.
20. Pertwee R.G. The ring test a quantitative method of assessing the 'cataleptic' effect of cannabis in mice . Br J Pharmacol. 46:1972;753-763.
21. Anisman H., Cygan D. Central effects of scopolamine and (+)-amphetamine on locomotor activity interaction with strain and stress variables . Neuropharmacology. 14:1975;835-840.
22. Evoniuk G.E., Hertzman R.P., Skolnick P. A rapid method for evaluating the behavioral effects of phencyclidine-like dissociative anesthetics in mice. Psychopharmacology (Berl). 105:1991;125-128.
23. Pellinen P., Honkakoski P., Stenback F., Niemitz M., Alhava E., Pelkonen O., Lang M.A., Pasanen M. Cocaine N-demethylation and the metabolism-related hepatotoxicity can be prevented by cytochrome P450 3A inhibitors. Eur J Pharmacol. 270:1994;35-43.
24. Pasanen M., Pellinen P., Stenback F., Juvonen R., Raunio H., Pelkonen O. The role of CYP enzymes in cocaine-induced liver damage. Arch Toxicol. 69:1995;287-290.
25. Bornheim L.M., Reid M.J. Influence of cannabinoids on brain levels of other drugs. FASEB J. 14:2000;A1480.
26. van Asperen J., Schinkel A.H., Beijnen J.H., Nooijen W.J., Borst P., van Tellingen O. Altered pharmacokinetics of vinblastine in Mdr1a P-glycoprotein-deficient mice. J Natl Cancer Inst. 88:1996;994-999.
27. Harvey D.J., Paton W.D.M. Metabolism of the cannabinoids. Hodgson E., Bend J.R., Philpot R.M. Reviews in biochemical toxicology. vol. 6:1986;221-264 Elsevier, New York.
28. Harvey D.J., Mechoulam R. Metabolites of cannabidiol identified in human urine. Xenobiotica. 20:1990;303-320.
29. Carroll M.E., Mattox A.J. Drug reinforcement in animals. Johnson B.A., Roache J.D. Drug addiction and its treatment nexus of neuroscience and behavior . 1997;3-37 Lippincott-Raven Publishers, Philadelphia.
30. Subjective and behavioral effects of diazepam depend on its rate of onset. Psychopharmacology (Berl). 112:1993;324-330.
31. Jaffe J.H. Drug addiction and drug use. Gilman A.G., Rall T.W., Nies A.S., Taylor P. Goodman and Gilman's the pharmacological basis of therapeutics. 1990;522-573 Pergamon, New York.
32. Meisch R.A., Kliner D.J., Henningfield J.E. Pentobarbital drinking by rhesus monkeys establishment and maintenance of pentobarbital-reinforced behavior . J Pharmacol Exp Ther. 217:1981;114-120.